Eunjung Lee1, Eric S Kawaguchi2, Juanjuan Zhang2, Sue E Kim2, Dennis Deapen3, Lihua Liu3, Nasim Sheidaee2, Amie E Hwang3, Irene Kang4, Kulmeet Sandhu5, Giske Ursin6, Anna H Wu3, Agustin A Garcia7. 1. Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California. Electronic address: leee@usc.edu. 2. Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California. 3. Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California. 4. University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California; Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California. 5. Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California. 6. Cancer Registry of Norway, Oslo, Norway. 7. Department of Medicine, Louisiana State University School of Medicine, New Orleans, Louisiana.
Abstract
BACKGROUND: The number of bariatric surgeries performed in the United States has increased substantially since the 1990's. However, the prevalence and prognostic impact of bariatric surgery, or weight loss surgery (WLS), among patients with cancer are not known. OBJECTIVES: We investigated the population-based prevalence of WLS in women with breast or endometrial cancer and conducted exploratory analysis to examine whether postdiagnosis WLS is associated with survival. SETTING: Administrative statewide database. METHODS: WLS records for women with nonmetastasized breast (n = 395,146) or endometrial (n = 69,859) cancer were identified from the 1991-2014 California Cancer Registry data linked with the California Office of Statewide Health Planning and Development database. Characteristics of the patients were examined according to history of WLS. Using body mass index data available since 2011, a retrospective cohort of patients with breast or endometrial cancer and obesity (n = 12,540) was established and followed until 2017 (5% lost to follow-up). Multivariable cause-specific Cox proportional hazards models were used to examine the associations between postdiagnostic WLS and time to death. RESULTS: WLS records were identified for 2844 (.7%) patients with breast cancer and 1140 (1.6%) patients with endometrial cancer; about half of the surgeries were performed after cancer diagnosis. Postdiagnosis WLS was performed in ∼1% of patients with obesity and was associated with a decreased hazard for death (cause-specific hazard ratio = .37; 95% confidence interval = .014-.99; P = .049), adjusting for age, stage, co-morbidity, race/ethnicity, and socioeconomic status. CONCLUSION: About 2000 patients with breast or endometrial cancer in California underwent post-diagnosis WLS between 1991 and 2014. Our data support survival benefits of WLS after breast and endometrial cancer diagnosis.
BACKGROUND: The number of bariatric surgeries performed in the United States has increased substantially since the 1990's. However, the prevalence and prognostic impact of bariatric surgery, or weight loss surgery (WLS), among patients with cancer are not known. OBJECTIVES: We investigated the population-based prevalence of WLS in women with breast or endometrial cancer and conducted exploratory analysis to examine whether postdiagnosis WLS is associated with survival. SETTING: Administrative statewide database. METHODS: WLS records for women with nonmetastasized breast (n = 395,146) or endometrial (n = 69,859) cancer were identified from the 1991-2014 California Cancer Registry data linked with the California Office of Statewide Health Planning and Development database. Characteristics of the patients were examined according to history of WLS. Using body mass index data available since 2011, a retrospective cohort of patients with breast or endometrial cancer and obesity (n = 12,540) was established and followed until 2017 (5% lost to follow-up). Multivariable cause-specific Cox proportional hazards models were used to examine the associations between postdiagnostic WLS and time to death. RESULTS: WLS records were identified for 2844 (.7%) patients with breast cancer and 1140 (1.6%) patients with endometrial cancer; about half of the surgeries were performed after cancer diagnosis. Postdiagnosis WLS was performed in ∼1% of patients with obesity and was associated with a decreased hazard for death (cause-specific hazard ratio = .37; 95% confidence interval = .014-.99; P = .049), adjusting for age, stage, co-morbidity, race/ethnicity, and socioeconomic status. CONCLUSION: About 2000 patients with breast or endometrial cancer in California underwent post-diagnosis WLS between 1991 and 2014. Our data support survival benefits of WLS after breast and endometrial cancer diagnosis.
Authors: Hannah Arem; Yikyung Park; Colleen Pelser; Rachel Ballard-Barbash; Melinda L Irwin; Albert Hollenbeck; Gretchen L Gierach; Louise A Brinton; Ruth M Pfeiffer; Charles E Matthews Journal: J Natl Cancer Inst Date: 2013-01-07 Impact factor: 13.506
Authors: Robert Neff; Georgia A McCann; Kristen M Carpenter; David E Cohn; Sabrena Noria; Dean Mikami; Bradley J Needleman; David M O'Malley Journal: Gynecol Oncol Date: 2014-06-14 Impact factor: 5.482
Authors: Brandon L Pierce; Rachel Ballard-Barbash; Leslie Bernstein; Richard N Baumgartner; Marian L Neuhouser; Mark H Wener; Kathy B Baumgartner; Frank D Gilliland; Bess E Sorensen; Anne McTiernan; Cornelia M Ulrich Journal: J Clin Oncol Date: 2009-05-26 Impact factor: 44.544
Authors: Rowan T Chlebowski; Juhua Luo; Garnet L Anderson; Wendy Barrington; Kerryn Reding; Michael S Simon; JoAnn E Manson; Thomas E Rohan; Jean Wactawski-Wende; Dorothy Lane; Howard Strickler; Yasmin Mosaver-Rahmani; Jo L Freudenheim; Nazmus Saquib; Marcia L Stefanick Journal: Cancer Date: 2018-10-08 Impact factor: 6.860
Authors: Juhua Luo; Michael Hendryx; JoAnn E Manson; Jane C Figueiredo; Erin S LeBlanc; Wendy Barrington; Thomas E Rohan; Barbara V Howard; Kerryn Reding; Gloria Yf Ho; David O Garcia; Rowan T Chlebowski Journal: JNCI Cancer Spectr Date: 2019-08-09